Third clinical trial

The third clinical trial aimed to demonstrate the biomarker feasibility to detect concussion in head injured children.

Sample collection of the third clinical trial was conducted by Satasairaala hospital in Pori, Finland. A total of 58 children and adolescents of age 0–17 years were recruited: 28 with suspected mild TBI and 30 healthy controls. 

The results reinforce the biomarker research results and provide evidence for the potential usability in children.